{"url_path":"/sec/mane/8-k/2026-07-15/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-15","source_url":"https://www.sec.gov/Archives/edgar/data/1827635/0001827635-26-000023-index.html","accession_number":"0001827635-26-000023","cik":"0001827635","ticker":"MANE","issuer_name":"Veradermics, Inc","edgar_url":"https://www.sec.gov/Archives/edgar/data/1827635/0001827635-26-000023-index.html","primary_entity_key":"0001827635","primary_entity_name":"Veradermics, Inc"},"word_count":88,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits\n\nExhibit No.Description\n\n99.1\n[Press release issued by the Company on July 15, 2026](exhibit991datarelease1.htm)\n\n99.2\n[Investor presentation dated July 15, 2026](a207_resultscallxfinal71.htm)\n\n104Cover Page Interactive Data File (embedded within the Inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nVERADERMICS, INCORPORATED\n\nBy:/s/ Reid Waldman, M.D.\n\nName: Reid Waldman, M.D.\n\nTitle: Chief Executive Officer\n\nDate: July 15, 2026"}